The Europe Veterinary Diagnostics Market has seen an exemplar shift in the past few years with the emergence of new and technologically advanced products, which had an optimistic impact on the overall growth of the market.
The European Parliament and the Council adopted the Regulation on transmissible animal diseases (“Animal Health Law”) in March 2016. The regulation will be applicable in the next five years. It’ll support the EU livestock sector in its quest towards competitiveness and safe and smooth EU market of animals and their products, creating growth for the veterinary diagnostics market. Veterinary diagnostic products are as complex as they are challenging to manufacture. Many of the poultry and livestock diagnostic products are biologic products that demand materials from living organisms. Market development for companion animal diagnostic has depended heavily upon the purchasing and using in-clinic analyzers or diagnostic instruments used at veterinary practices.
Factors such as growing Zoonotic diseases in animals and increasing the number of veterinary practitioners in Europe, and on-going increase in the demand for animal protein are primarily driving the veterinary diagnostics market in Europe.
Growing technological support to diagnose animal diseases, increasing product launches, rising partnerships between the major companies is majorly propelling market growth. Rising per capita income in Europe and growing awareness among the pet owners regarding their pet animal’s health, and an increasing number of in-clinical diagnostic methods are forecasted to boost the market.
The high costs associated with the veterinary diagnostics and the restorative steps for animal diseases are expected to restrain the market.
This research report on the Europe Veterinary Diagnostics Market has been segmented and sub-segmented into the following categories:
Regional Analysis:
The European Veterinary Diagnostics Market was accounted for the second-largest share in the global market in 2019. It is predicted that this market will grow at a robust CAGR during the forecast period.
UK market for veterinary diagnostics is projected to be the accounting largest share in the European market from 2020 to 2025 due to the growing expenditure on pets. Increasing importance to prevent and control zoonotic animal diseases straight away from the human population across Europe, and growing demand for pet insurance, an increasing number of veterinary clinics are driving the market.
The German veterinary diagnostics market is forecasted to hike at a favorable rate during the forecast period due to rising animal healthcare expenditure, growing pet adoption, and increasing demand for animal-derived food products.
France, Italy, and Spain are expected to have considerable and yet a notable growth during the forecast period.
Major companies operating in the European Veterinary Diagnostics Market profiled in this report are VCA Inc., Heska Corporation, Abaxis Inc., VIRBAC, IDEXX Laboratories Inc., Life Technologies Corporation, Bio-Rad Laboratories Inc., Prionics AG, and Pfizer. Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Clinical Chemistry
5.1.1.1 Urine Analysis
5.1.1.2 Glucose Monitoring
5.1.1.3 Blood Gas Electrolyte Analysis
5.1.2 Molecular Diagnostics
5.1.2.1 Micro Arrays
5.1.2.2 PCR Tests
5.1.2.3 Other Molecular Diagnostics Tests
5.1.3 Haemotology
5.1.3.1 Haemotology Analysers
5.1.3.2 Haemotology Catridges
5.1.4 Diagnostic Imaging
5.1.4.1 Radiography Systems
5.1.4.2 Ultrasound Imaging Systems
5.1.4.3 CT Scanners
5.1.4.4 MRI Scanners
5.1.5 Immunodiagnostics
5.1.5.1 Immunoassay Analysers
5.1.5.2 ELISA Tests
5.1.5.3 Lateral-Flow Strip Readers
5.1.5.4 Lateral-Flow Rapid Tests
5.1.5.5 Allergen specific Immunodiagnostic Tests
5.2 By Animals
5.2.1 Companion Animals
5.2.1.1 Canine Diagnostics
5.2.1.2 Feline Diagnostics
5.2.1.3 Other Veterinary Diagnostics
5.2.2 Food-Producing Animals
5.2.2.1 Bovine Diagnostics
5.2.2.2 Porcine Diagnostics
5.2.2.3 Ovine Diagnostics
5.2.2.4 Poultry Diagnostics
5.2.2.5 Piscine Diagnostics
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Abaxis Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Heska Corporation
8.3 VCA Inc.
8.4 IDEXX Laboratories
8.5 Life Technologies Corporation
8.6 Bio-Rad Laboratories Inc.
8.7 Prionics AG
8.8 Pfizer Inc.
8.9 VIRBAC
8.10 Zoetis Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
